Reasons Why Post-Trial Access to Trial Drugs Should, or Need not be Ensured to Research Participants: A Systematic Review
Author:
Publisher
Oxford University Press (OUP)
Subject
Health Policy,Issues, ethics and legal aspects
Link
http://academic.oup.com/phe/article-pdf/4/2/160/17170251/phr013.pdf
Reference51 articles.
1. Human rights and maternal-fetal HIV transmission prevention trials in Africa.
2. HIV INTERNATIONAL CLINICAL RESEARCH: EXPLOITATION AND RISK
3. Populations who test drugs should benefit from them
4. Thorny issues in the ethics of AIDS vaccine trials
Cited by 66 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Towards achieving transnational research partnership equity: lessons from implementing adaptive platform trials in low- and middle-income countries;Wellcome Open Research;2023-12-06
2. When the Trial Ends: The Case for Post-Trial Provisions in Clinical Psychedelic Research;Neuroethics;2023-11-06
3. What can the citations of systematic reviews of ethical literature tell us about their use?—an explorative empirical analysis of 31 reviews;Systematic Reviews;2023-09-23
4. Afterlife: the post-research affect and effect of software;Research Ethics;2023-06-10
5. The shared ethical framework to allocate scarce medical resources: a lesson from COVID-19;The Lancet;2023-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3